The aim of the 3rd UUÂãÁÄÖ±²¥â€“BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late-stage medicinal chemistry, preclinical or clinical programmes. These case studies will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.
Fragments III
7 - 8 March 2011, Stevenage, United Kingdom
Introduction
Sponsorship & supporting organisations
GSK,AstraZeneca, Astex Pharmaceuticals, Pfizer, Selcia, Pharma Diagnostics, CCDC
Venue
GlaxoSmithKline
Conference Room, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Contact information
Related events
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
Conference on Advances in Chemistry for Energy and Environment (CACEE-2024)
16 December 2024 13:00 - 20 December 2024 15:00, Mumbai , India
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
